Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Heba Degheidy"'
Publikováno v:
Clinical and Translational Medicine, Vol 14, Iss 5, Pp n/a-n/a (2024)
Abstract Background Previously, we discovered that human solid tumours, but not normal human tissues, preferentially overexpress interleukin‐13Receptor alpha2, a high binding receptor for IL‐13. To develop novel anti‐cancer approaches, we const
Externí odkaz:
https://doaj.org/article/3ec837ceb5c14fce9430dd4a6f1980ce
Autor:
Siddha Kasar, Chingiz Underbayev, Moinuddin Hassan, Ilko Ilev, Heba Degheidy, Steven Bauer, Gerald Marti, Carol Lutz, Elizabeth Raveche, Mona Batish
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149331 (2016)
New Zealand Black (NZB) mice, a de novo model of CLL, share multiple characteristics with CLL patients, including decreased expression of miR-15a/16-1. We previously discovered a point mutation and deletion in the 3' flanking region of mir-16-1 of NZ
Externí odkaz:
https://doaj.org/article/240691af79bb467eb52b2f9e2561aaaa
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::952225d9e3a072cdf62e196ef1665b19
https://doi.org/10.1136/jitc-2022-sitc2022.0344
https://doi.org/10.1136/jitc-2022-sitc2022.0344
3D bioprinting optimization of human mesenchymal stromal cell laden gelatin-alginate-collagen bioink
Autor:
Stephen W Sawyer, Kazuyo Takeda, Alaadin Alayoubi, Eman Mirdamadi, Ahmed Zidan, Steven R Bauer, Heba Degheidy
Publikováno v:
Biomedical materials (Bristol, England). 18(1)
3D bioprinting technology has gained increased attention in the regenerative medicine and tissue engineering communities over the past decade with their attempts to create functional living tissues and organs de novo. While tissues such as skin, bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7e70beb80f21c502d20adf02554a8f71
https://pubmed.ncbi.nlm.nih.gov/36395510
https://pubmed.ncbi.nlm.nih.gov/36395510
Publikováno v:
Journal of Biomedical Science and Engineering. :756-768
There is an urgent need for developing a procedure for biomarker standardization and relative quantificationin clinical laboratories. Measuring the expression levels of cell antigens is critical for the diagnosis of many diseases, e.g. leukemia, lymp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b5710ad3e867de76278040c90a74592f
https://doi.org/10.4236/jbise.2014.79074
https://doi.org/10.4236/jbise.2014.79074
Autor:
F Badiane, H Khan, Siddha Kasar, Chingiz Underbayev, Mona Batish, Gerald Marti, Heba Degheidy, Yao Yuan, T Gavrilova, Shaban Aly, Victor T. Chang, M Hanlon, Elizabeth Raveche
Publikováno v:
Oncogene
Genetic lesions and other regulatory events lead to silencing of the 13q14 locus in a majority of chronic lymphocytic leukemia (CLL) patients. This locus encodes a pair of critical proapoptotic microRNAs, miR-15a/16-1. Decreased levels of miR-15a/16-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35934e59234e5faaa9f703535b5d5fd4
https://doi.org/10.1038/onc.2013.291
https://doi.org/10.1038/onc.2013.291
Autor:
Chingiz Underbayev, Siddha Kasar, Gerald Marti, William Ruezinsky, Elizabeth Raveche, Mona Batish, Heba Degheidy, Steven R. Bauer, Vijay Parashar, Joel S. Schneider, Marilyn Lightfoote, Diego Fraidenraich
Publikováno v:
Oncotarget
// Chingiz Underbayev 1,6 , Siddha Kasar 1 , William Ruezinsky 1 , Heba Degheidy 3,7 , Joel Solomon Schneider 4 , Gerald Marti 2 , Steven R. Bauer 3 , Diego Fraidenraich 1 , Marilyn M. Lightfoote 3 , Vijay Parashar 5 , Elizabeth Raveche 1 and Mona Ba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2280ab9911aab2d39622b81c9b188185
https://pubmed.ncbi.nlm.nih.gov/27533467
https://pubmed.ncbi.nlm.nih.gov/27533467
Autor:
Heba, Degheidy, Fatima, Abbasi, Howard, Mostowski, Adolfas K, Gaigalas, Gerald, Marti, Steven, Bauer, Lili, Wang
Publikováno v:
Cytometry. Part B, Clinical cytometry. 90(2)
Detecting changes in the expression levels of cell antigens could provide critical information for the diagnosis of many diseases, for example, leukemia, lymphoma, and immunodeficiency diseases, detecting minimal residual disease, monitoring immunoth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::908f38ddd5373666e37877fbab2625a4
https://pubmed.ncbi.nlm.nih.gov/26013593
https://pubmed.ncbi.nlm.nih.gov/26013593
Autor:
Marilyn Lightfoote, Gerald Marti, Elizabeth Raveche, Smruti Mehta, Chingiz Underbayev, Siddha Kasar, Yao Yuan, Heba Degheidy
Publikováno v:
MicroRNA in Development and in the Progression of Cancer ISBN: 9781489980649
MicroRNA abnormalities are involved in the development and progression of chronic lymphocytic leukemia (CLL). In the majority of CLL malignant cluster of differentiation CD5+ (B-1) clones, the expression of miR-15a/16 is decreased relative to polyclo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1cc623109327a78bf9282e4bf6cad2bc
https://doi.org/10.1007/978-1-4899-8065-6_9
https://doi.org/10.1007/978-1-4899-8065-6_9
Autor:
Carol S. Lutz, Chingiz Underbayev, Gerald Marti, Steven R. Bauer, Heba Degheidy, Elizabeth Raveche, Siddha Kasar, Ilko K. Ilev, Moinuddin Hassan, Mona Batish
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0149331 (2016)
PLoS ONE
PLoS ONE
New Zealand Black (NZB) mice, a de novo model of CLL, share multiple characteristics with CLL patients, including decreased expression of miR-15a/16-1. We previously discovered a point mutation and deletion in the 3' flanking region of mir-16-1 of NZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09e70af12b6194486b1240880fc36553
https://doi.org/10.1371/journal.pone.0149331
https://doi.org/10.1371/journal.pone.0149331